The fusion between DNA and IT

welcome in a new era!

We are the bridge between two sources of information, DNA and computer science. For this purpose, we built the first secure infrastructure including a biobank, a genetics lab and a datacenter. We can thus ensure the digital continuity between the patient and the personalized medicine, but also ensure the links between health professionals and pharmaceutical companies.

Our infrastructures



Our services

  • Genetic Analysis

    Genetic analysis is the overall process of studying and researching in fields of science that involve genetics and molecular biology. There are a number of applications that are developed from this research, and these are also considered parts of the process. The base system of analysis revolves around general genetics. Basic studies include identification of…

  • Genetic Disorder

    Genetic disorders may be hereditary, passed down from the parents' genes. In other genetic disorders, defects may be caused by new mutations or changes to the DNA. In such cases, the defect will only be passed down if it occurs in the germ line. The same disease, such as some forms of cancer, may be…

  • Microbiome

    The human microbiota is the aggregate of microorganisms, a microbiome that resides on or within a number of tissues and biofluids, including the skin, mammary glands, placenta, seminal fluid, uterus, ovarian follicles, lung, saliva, oral mucosa, conjunctiva, and gastrointestinal tracts. They include bacteria, fungi, and archaea. Micro-animals which live on the human body are excluded.…

  • Cancer analysis

    A cancer syndrome or family cancer syndrome is a genetic disorder in which inherited genetic mutations in one or more genes predispose the affected individuals to the development of cancers and may also cause the early onset of these cancers. Cancer syndromes often show not only a high lifetime risk of developing cancer, but also…


Our researches

Cell-free or circulating tumour DNA (ctDNA) is tumour DNA circulating freely in the blood of a cancer patient. Analysis of the fraction of mutant-alleles from ctDNA compared to normal-alleles from the patients normal genome provides opportunities for minimally-invasive cancer diagnosis, prognosis and tumour monitoring.

Contact: Patrick Segu     LinkedIn